Matias L. Ferraris
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Comparative effectiveness of erenumab versus rimegepant for migraine prevention using matching-adjusted indirect comparison.
Journal: Journal of comparative effectiveness research
Published: January 04, 2024
Real-world treatment satisfaction with erenumab in migraine: analysis of the US National Health and Wellness Survey.
Journal: Current medical research and opinion
Published: March 15, 2023
Healthcare costs and resource utilization in patients with migraine treated with erenumab: A retrospective, non-interventional study using claims data from the United States.
Journal: Headache
Published: January 27, 2023
Assessment of the relative effectiveness of erenumab compared with onabotulinumtoxinA for the prevention of chronic migraine.
Journal: Current medical research and opinion
Published: October 03, 2022
Real-world migraine-related healthcare resource utilization and costs associated with improved vs. worsened/stable migraine: a panel-based chart review in France, Germany, Italy, and Spain.
Journal: Journal of medical economics
Published: July 27, 2021
Correction to: Real-World Trends in Characteristics of Patients with Migraine Newly Initiated on Erenumab in the USA: A Retrospective Analysis.
Journal: Advances in therapy
Published: July 17, 2021
Correction to: Real-World Trends in Characteristics of Patients with Migraine Newly Initiated on Erenumab in the USA: A Retrospective Analysis.
Journal: Advances in therapy
Published: May 18, 2021
Effectiveness of erenumab and onabotulinumtoxinA on acute medication usage and health care resource utilization as migraine prevention in the United States.
Journal: Journal of managed care & specialty pharmacy
Published: May 17, 2021
Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database study.
Journal: The journal of headache and pain
Published: February 16, 2021
Real-World Trends in Characteristics of Patients with Migraine Newly Initiated on Erenumab in the USA: A Retrospective Analysis.
Journal: Advances in therapy
Published: December 31, 2020
Management of Migraine and the Accessibility of Specialist Care: Findings from an Extended Multinational Survey (My Migraine Center Survey).
Journal: Neurology and therapy
Published: December 09, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026